Bill

Bill > HR1325


US HR1325

US HR1325
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013


summary

Introduced
03/21/2013
In Committee
04/10/2013
Crossed Over
Passed
Dead
01/03/2015

Introduced Session

113th Congress

Bill Summary

Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013 - Amends title II (Old Age, Survivors and Disability Benefits) (OASDI) of the Social Security Act (SSA) to extend the months of coverage of immunosuppressive drugs for kidney transplant patients. Amends SSA title XVIII (Medicare) to make eligible for enrollment in Medicare part B (Supplementary Medical Insurance), solely for the purpose of such drug coverage, every individual whose insurance benefits under Medicare part A (Hospital Insurance) have ended by reason of a kidney transplant or the end of any requirement for a regular course of dialysis. Directs the Secretary of Health and Human Services (HHS) to determine a monthly premium rate for such individuals equal to 35% of the monthly actuarial rate for enrollees age 65 and over. Prescribes a formula for detemination of a government contribution to such a premium.

AI Summary

This bill, the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013, aims to expand Medicare coverage for kidney transplant recipients. Specifically, it allows individuals whose Medicare Part A (Hospital Insurance) benefits have ended due to a kidney transplant or the cessation of dialysis to enroll in Medicare Part B (Supplementary Medical Insurance) solely for the purpose of covering immunosuppressive drugs, which are crucial for preventing organ rejection after a transplant. The bill also establishes a monthly premium for these individuals, set at 35% of the average monthly rate for Medicare beneficiaries aged 65 and over, and outlines a formula for the government's contribution to this premium.

Committee Categories

Business and Industry, Health and Social Services

Sponsors (16)

Last Action

Referred to the Subcommittee on Health. (on 04/10/2013)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...